» Articles » PMID: 2496142

Epidemiologic Evidence for the Development of Serovar-specific Immunity After Gonococcal Infection

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1989 May 1
PMID 2496142
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

We tested the hypothesis that strain-specific immunity occurs after gonococcal infection in a longitudinal study of 227 prostitutes resident in one small community who experienced frequent gonococcal infections. Women were examined and cultured for Neisseria gonorrhoeae at 2-wk intervals. Gonococcal isolates were typed according to protein 1 serovar, auxotype, and beta-lactamase plasmid type, and classified as to serovar and strain. The hypothesis was tested by comparing the predictions of the hypothesis with the observations of the study. Over the 14-mo period of the study, major changes in the prevalence of specific serovars were observed in the gonococcal population infecting these women. Women with HIV infection experienced a higher rate of gonococcal infection (0.56 +/- 0.03 vs. 0.46 +/- 0.04, P less than 0.05, t test) compared with HIV-negative women and were more likely to experience multiple infections with the same strain. The duration of prostitution was inversely related to the frequency of gonococcal infection. Women experiencing an infection with a specific gonococcal serovar were at a 2- to 10-fold reduced risk of reinfection with the same serovar, except for the 1B-1 serovar. The results of the study were consistent with all four predictions of the hypothesis. Infection with a specific gonococcal serovar results in specific but incomplete protection against subsequent infection with the homologous serovar. The mechanism of this protection remains to be determined.

Citing Articles

Tackling immunosuppression by Neisseria gonorrhoeae to facilitate vaccine design.

Jones R, Ramirez-Bencomo F, Whiting G, Fang M, Lavender H, Kurzyp K PLoS Pathog. 2024; 20(11):e1012688.

PMID: 39541395 PMC: 11594432. DOI: 10.1371/journal.ppat.1012688.


Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Stejskal L, Thistlethwaite A, Ramirez-Bencomo F, Rashmi S, Harrison O, Feavers I Nat Commun. 2024; 15(1):6712.

PMID: 39112489 PMC: 11306574. DOI: 10.1038/s41467-024-51053-x.


Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.

Blaylock J, Ewers E, Bianchi E, King D, Casimier R, Erazo H PLoS One. 2023; 18(12):e0296054.

PMID: 38153953 PMC: 10754448. DOI: 10.1371/journal.pone.0296054.


In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics.

Roe S, Felter B, Zheng B, Ram S, Wetzler L, Garges E Vaccines (Basel). 2023; 11(12).

PMID: 38140249 PMC: 10747275. DOI: 10.3390/vaccines11121846.


Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved SliC antigen that blocks human lysozyme.

Martinez F, Zielke R, Fougeroux C, Li L, Sander A, Sikora A Infect Immun. 2023; 91(12):e0024523.

PMID: 37916806 PMC: 10715030. DOI: 10.1128/iai.00245-23.


References
1.
Hook 3rd E, Olsen D, Buchanan T . Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect Immun. 1984; 43(2):706-9. PMC: 264357. DOI: 10.1128/iai.43.2.706-709.1984. View

2.
Knapp J, Tam M, Nowinski R, Holmes K, Sandstrom E . Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis. 1984; 150(1):44-8. DOI: 10.1093/infdis/150.1.44. View

3.
Gotschlich E . Development of a gonorrhoea vaccine: prospects, strategies and tactics. Bull World Health Organ. 1984; 62(5):671-80. PMC: 2536225. View

4.
DCosta L, Plummer F, Bowmer I, Fransen L, Piot P, Ronald A . Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis. 1985; 12(2):64-7. DOI: 10.1097/00007435-198504000-00002. View

5.
Lammel C, Sweet R, Rice P, Knapp J, Schoolnik G, Heilbron D . Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis. 1985; 152(5):990-1001. DOI: 10.1093/infdis/152.5.990. View